Rhoen Klinikum AG
XETRA:RHK

Watchlist Manager
Rhoen Klinikum AG Logo
Rhoen Klinikum AG
XETRA:RHK
Watchlist
Price: 15 EUR 1.35% Market Closed
Market Cap: 1B EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one RHK stock under the Base Case scenario is 18.14 EUR. Compared to the current market price of 15 EUR, Rhoen Klinikum AG is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RHK Relative Value
Base Case
18.14 EUR
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
58
vs Industry
76
Median 3Y
0.6
Median 5Y
0.7
Industry
2.2
Forward
0.6
More Details
23.2
P/E
P/E
Price to Earnings
23.2
vs History
74
vs Industry
28
Median 3Y
25
Median 5Y
34
Industry
21.8
Forward
21.5
More Details
7.9
P/OCF
P/OCF
Price to OCF
7.9
vs History
76
vs Industry
46
Median 3Y
10.3
Median 5Y
9.8
Industry
13.4
More Details
19.6
P/FCFE
P/FCFE
Price to FCFE
19.6
vs History
39
vs Industry
27
Median 3Y
13.9
Median 5Y
17.5
Industry
19
More Details
0.8
P/B
P/B
Price to Book Value
0.8
vs History
58
vs Industry
72
Median 3Y
0.7
Median 5Y
0.8
Industry
2.1
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
74
vs Industry
86
Median 3Y
0.3
Median 5Y
0.5
Industry
2.3
Forward
0.3
More Details
0.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.5
vs History
74
vs Industry
87
Median 3Y
0.5
Median 5Y
0.8
Industry
4.8
More Details
4.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.5
vs History
74
vs Industry
50
Median 3Y
4.6
Median 5Y
7.4
Industry
11.4
Forward
4.4
More Details
10.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.4
vs History
79
vs Industry
39
Median 3Y
12.7
Median 5Y
21
Industry
15.5
Forward
9.2
More Details
4
EV/OCF
EV/OCF
Enterprise Value to OCF
4
vs History
79
vs Industry
53
Median 3Y
8.1
Median 5Y
7.9
Industry
13.3
More Details
8.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.8
vs History
53
vs Industry
39
Median 3Y
6.8
Median 5Y
10.5
Industry
17.1
More Details
0.4
EV/IC
EV/IC
Enterprise Value to IC
0.4
vs History
66
vs Industry
81
Median 3Y
0.4
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

RHK Competitors Multiples
Rhoen Klinikum AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Rhoen Klinikum AG
XETRA:RHK
1B EUR 0.6 23.2 4.5 10.4
US
HCA Healthcare Inc
NYSE:HCA
82B USD 1.2 14.2 8.5 11.2
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 8.7 42.3 37.1 43.8
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
20.9B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
18B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
122.3B CNY 5.9 33.7 25.4 25.4
MY
IHH Healthcare Bhd
KLSE:IHH
60.5B MYR 2.5 22.8 12 17.1
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1T INR 15.9 102.9 61.9 74.8
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
69.8B BRL 1.4 18.1 7.3 8.9
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
999.7B INR 4.7 76.3 36.1 47.6
US
Tenet Healthcare Corp
NYSE:THC
11.6B USD 0.6 3.6 5.4 6.7

See Also

Summary
RHK intrinsic value, competitors valuation, and company profile.
DCF Valuation
RHK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RHK stock valuation using valuation multiples.
Wall Street Estimates
RHK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RHK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.